Montelukast Prescribing at MORLAND HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
635
Total Quantity
16.7K
NHS Cost
£850
vs National Avg
-7.3%
MORLAND HOUSE SURGERY prescribed 635 items of Montelukast over the last 12 months at a cost of £850 to the NHS. This is 7.3% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
57
Jul 2026
45
Jul 2026
51
Jul 2026
51
Jul 2026
56
Jul 2026
61
Jul 2026
54
Jul 2026
56
Jul 2026
61
Jul 2026
48
Jul 2026
52
Jul 2026
43
Prescribing Details
| Total Items | 635 |
|---|---|
| Total Quantity | 16,688 |
| Total NHS Cost | £850 |
| Presentations | 4 different forms |
| vs National Average | -7.3% |
Montelukast Prescribing Comparison
| This practice | 635 items |
|---|---|
| National average per practice | 685 items |
| Difference | -7.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.